# LO LARIN FE
> **ANDA208661** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2016-12-20
## Drug
- **FDA Application Number:** ANDA208661
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LO LARIN FE
- **Generic name:** Ethinyl Estradiol
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NOVAST LABS LTD
- **First approval:** 2016-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208661)
---
*AI Analytics · CC0 1.0*